 |
 |
|
|
RESÚMENES SEPTIEMBRE 2004 |
Other Neuropsychiatric Disorders
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Peter Tyrer
and Anthony W. Bateman
Advances in Psychiatric Treatment (2004) 10: 389-398
Rob Butler
; Martin Orrell ; Obioha
C. Ukoumunne ; Paul Bebbington
Australian and New Zealand Journal
of Psychiatry 2004; Volume: 38 Number: 9 Page: 702 -- 705
STRATEGIES FOR DISEASE
MODIFICATION IN ALZHEIMER'S DISEASE
Nature Reviews Neuroscience 5, 677-685 (2004)
Side Effects of Antiepileptics
A Review
Kulbir S. Walia, Elizabeth A.
Khan, Dong H. Ko, Shariq S.
Raza, Yasin N. Khan
Pain Practice. Volume 4 Issue 3 Page
194 - September 2004
Family Transmission and Heritability of
Externalizing Disorders . A
Twin-Family Study
Brian M.
Hicks, Robert F. Krueger, William G. Iacono, Matt McGue, Christopher J. Patrick
Arch Gen Psychiatry. 2004;61:922-928.
Alzheimer Disease With Psychosis. Excess Cognitive Impairment Is Restricted to the Misidentification Subtype
Gina Perez-Madriñan, Sarah E.
Cook, Judith A. Saxton, Sachiko Miyahara, Oscar L.
Lopez, Daniel I. Kaufer, Howard J. Aizenstein, Steven T. DeKosky,
and Robert A. Sweet
Am J Geriatr
Psychiatry 12:449-456, October 2004
Constantine G. Lyketsos, William
E. Reichman, Paul Kershaw, and Young Zhu
Am J Geriatr
Psychiatry 12:473-482, October 2004
Cognitive
Response to Pharmacological Treatment for Depression in Alzheimer Disease
Secondary
Outcomes From the Depression in Alzheimer's Disease
Study (DIADS)
Cynthia A. Munro, Jason Brandt, Jeannie-Marie E. Sheppard,
Cynthia D. Steele, Quincy M. Samus, Martin Steinberg,
Peter V. Rabins, and Constantine G. Lyketsos
Am J Geriatr
Psychiatry 12:491-498, October 2004
Risperidone and Falls in Ambulatory Nursing Home Residents With Dementia and Psychosis or Agitation. Secondary Analysis of a Double-Blind, Placebo-Controlled Trial
Ira R. Katz, Marcia Rupnow, Chris
Kozma, and Lon Schneider
Am J Geriatr
Psychiatry 12:499-508, October 2004
Effect of Galantamine
Hydrobromide in Chronic Fatigue Syndrome. A
Randomized Controlled Trial
C. V.
Russell Blacker, David T. Greenwood, Keith A. Wesnes,
Rosamund Wilson, Carol Woodward, Ian Howe, Tauhid Ali
Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
Natalie J Ives, Rebecca L Stowe, Joanna Marro, Carl Counsell,
Angus
Macleod, Carl E Clarke, Richard Gray,
Keith
Wheatley
BMJ 2004;329:593 (11 September)
BDNF
and 5-HT: a dynamic duo in age-related neuronal plasticity and
neurodegenerative disorders
Mark P.
Mattson, Stuart Maudsley and Bronwen
Martin
Can J Psychiatry 2004;49:517–525
The Boundary Between Borderline Personality Disorder and Bipolar Disorder: Current Concepts and Challenges
Can J Psychiatry 2004;49:551–556
The presence of psychiatric disorders
reduces the likelihood of neurologic disease among
referrals to a neurology clinic
John R. Ekstrand, Patrick G. O'Malley,
Robert J. Labutta and Jeffery L. Jackson
J Psychosomatic Res Vol 57;Pages 11-16 (July 2004)
Depression in patients with mild cognitive
impairment increases the risk of developing dementia of Alzheimer type: a
prospective cohort study.
Modrego PJ, Ferrandez
J.
Arch Neurol. 2004 Aug;61(8):1290-3
Olanzapine
in the treatment of developmental stuttering: a double-blind,
placebo-controlled trial.
Ann Clin Psychiatry. 2004
Apr-Jun;16(2):63-7
On-demand treatment of premature ejaculation with clomipramine and paroxetine: a
randomized, double-blind fixed-dose study with stopwatch assessment.
Waldinger MD, Zwinderman AH, Olivier B.
Eur Urol. 2004 Oct;46(4):510-6
Stephen V.Faraone
Primary Psychiatry.2004;11(7):28-40
Eric Mick, Stephen V.Faraone,
Joseph Biederman, and Thomas J.Spencer
Primary Psychiatry.2004;11(7):42-48
Clinical, Cognitive, and Neurophysiologic
Correlates of Short-Term Treatment with Carbamazepine,
Oxcarbazepine, and Levetiracetam
in Healthy Volunteers
Mecarelli O, Vicenzini
E, Pulitano P, Vanacore N, Romolo FS, Di Piero
V, Lenzi GL, Accornero N.
Ann Pharmacother. 2004 Sep
14 [Epub ahead of print]
Cognitive Behavior Therapy and Pharmacotherapy
for Insomnia. A Randomized
Controlled Trial and Direct Comparison
Gregg D. Jacobs, Edward F. Pace-Schott, Robert Stickgold, Michael W. Otto
Arch Intern Med. 2004;164:1888-1896
Citalopram treatment of depression in Parkinson's disease: the impact on
anxiety, disability, and cognition.
Menza M, Marin H, Kaufman K, Mark M, Lauritano M.